121 related articles for article (PubMed ID: 4005393)
1. Lack of effect of liver disease on the pharmacokinetics of acebutolol and diacetolol: a single dose study.
Zaman R; Jack DB; Wilkins MR; Kendall MJ
Biopharm Drug Dispos; 1985; 6(2):131-7. PubMed ID: 4005393
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
[TBL] [Abstract][Full Text] [Related]
3. Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method.
Sankey MG; Gulaid A; Kaye CM
J Pharm Pharmacol; 1984 Apr; 36(4):276-7. PubMed ID: 6144783
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).
Gulaid AA; James IM; Kaye CM; Lewellen OR; Roberts E; Sankey M; Smith J; Templeton R; Thomas RJ
Biopharm Drug Dispos; 1981; 2(2):103-14. PubMed ID: 7248475
[TBL] [Abstract][Full Text] [Related]
5. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
Choi JS; Burm JP
Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
[TBL] [Abstract][Full Text] [Related]
7. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].
Kukes VG; Gneushev ET; Mamedov TSh; Gneusheva IA
Farmakol Toksikol; 1991; 54(1):53-5. PubMed ID: 1860501
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
[TBL] [Abstract][Full Text] [Related]
9. The effect of food and alcohol on the pharmacokinetics of acebutolol and its metabolite, diacetolol.
Zaman R; Wilkins MR; Kendall MJ; Jack DB
Biopharm Drug Dispos; 1984; 5(1):91-5. PubMed ID: 6704510
[No Abstract] [Full Text] [Related]
10. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
Mostafavi SA; Foster RT
Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
[TBL] [Abstract][Full Text] [Related]
11. Acebutolol and diacetolol plasma levels in patients undergoing myocardial revascularization with hypothermic cardiopulmonary bypass.
Mantz J; Blanchot G; Marty J; Farinotti R; Trouvin JH; Hazebroucq J; Desmonts JM
J Cardiothorac Anesth; 1990 Oct; 4(5):577-81. PubMed ID: 2132136
[TBL] [Abstract][Full Text] [Related]
12. Observations on the clinical pharmacology and plasma concentrations of diacetolol, the major human metabolite of acebutolol.
Ohashi K; Warrington SJ; Kaye CM; Houghton GW; Dennis M; Templeton R; Turner P
Br J Clin Pharmacol; 1981 Oct; 12(4):561-5. PubMed ID: 7295489
[TBL] [Abstract][Full Text] [Related]
13. The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.
Zaman R; Jack DB; Kendall MJ
Br J Clin Pharmacol; 1981 Sep; 12(3):427-9. PubMed ID: 7295474
[No Abstract] [Full Text] [Related]
14. Separation of acebutolol and diacetolol diastereomers by reversed-phase high-performance liquid chromatography.
Gulaid AA; Houghton GW; Boobis AR
J Chromatogr; 1985 Jan; 318(2):393-7. PubMed ID: 3980629
[No Abstract] [Full Text] [Related]
15. To nurse when receiving acebutolol: is it dangerous for the neonate?
Boutroy MJ; Bianchetti G; Dubruc C; Vert P; Morselli PL
Eur J Clin Pharmacol; 1986; 30(6):737-9. PubMed ID: 3770068
[TBL] [Abstract][Full Text] [Related]
16. Acebutolol pharmacokinetics in renal failure.
Smith RS; Warren DJ; Renwick AG; George CF
Br J Clin Pharmacol; 1983 Sep; 16(3):253-8. PubMed ID: 6626416
[TBL] [Abstract][Full Text] [Related]
17. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
Munn S; Bailey RR; Begg E; Ebert R; Ferry DG
N Z Med J; 1980 Apr; 91(658):289-91. PubMed ID: 6930006
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
Szymura-Oleksiak J; Walczak M; Bojarski J; Aboul-Enein HY
Chirality; 1999; 11(4):267-71. PubMed ID: 10224653
[TBL] [Abstract][Full Text] [Related]
19. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma.
Jiang H; Randlett C; Junga H; Jiang X; Ji QC
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):173-80. PubMed ID: 19109073
[TBL] [Abstract][Full Text] [Related]
20. Blood plasma binding of acebutolol and diacetolol in man.
Coombs TJ; Coulson CJ; Smith VJ
Br J Clin Pharmacol; 1980 Apr; 9(4):395-7. PubMed ID: 7378256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
